Tag Archives: File No

Zoetis™ to Host Webcast and Conference Call on First-Quarter 2013 Financial Results

By Business Wirevia The Motley Fool

Filed under:


Zoetis™ to Host Webcast and Conference Call on First-Quarter 2013 Financial Results

MADISON, N.J.–(BUSINESS WIRE)– ZoetisTM (NYS: ZTS) , formerly the animal health business of Pfizer Inc., will host a webcast and conference call at 8:30 a.m. (EDT) on Tuesday, April 30, 2013. Chief Executive Officer Juan Ramón Alaix and Executive Vice President and Chief Financial Officer Rick Passov will review first-quarter 2013 financial results, discuss 2013 financial guidance, and respond to questions from financial analysts during the call.

Investors and the public may access the live webcast by visiting the Zoetis website at http://www.zoetis.com/events-and-presentations. Information on accessing and pre-registering for the webcast is available beginning today. A replay of the webcast will be archived and made available on April 30.

About Zoetis

Zoetis (zō-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on a 60-year history as the animal health business of Pfizer, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, with a focus on both farm and companion animals. The company generated annual revenues of $4.2 billion in 2011. It had approximately 9,500 employees and a local presence in approximately 70 countries, including 29 manufacturing facilities in 11 countries. Its products serve veterinarians, livestock producers and people who raise and care for farm and companion animals in 120 countries.


DISCLOSURE NOTICE
: This news release contains forward-looking statements, which reflect Zoetis’ current views with respect to business plans or prospects, future operating or financial performance, and other future events. These statements are not guarantees of future performance. Forward-looking statements are subject to risks and uncertainties. If one or more of these risks or uncertainties materialize, or if management’s underlying assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Forward-looking statements speak only as of the date on which they are made. Zoetis expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. A further list and description of these risks, uncertainties and other factors can be found in Zoetis’ Registration Statement on Form S-1 (File No. 333-183254), as amended, …read more
Source: FULL ARTICLE at DailyFinance

Atlas Announces Exercise of Underwriters Option in US IPO

By Business Wirevia The Motley Fool

Filed under:

Atlas Announces Exercise of Underwriters Option in US IPO

CHICAGO–(BUSINESS WIRE)– Atlas Financial Holdings, Inc. (NASDAQ: AFH; TSX.V: AFH) (“Atlas” or the “Company”) today announced that the underwriters of the Company’s recently completed initial public offering have purchased an additional 451,500 ordinary shares from the Company, pursuant to their over-allotment option, at the initial public offering price of $5.85 per share, less underwriting discounts and commissions.

Sandler O’Neill + Partners, L.P. acted as the book-running manager for the offering. Sterne, Agee & Leach, Inc., EarlyBirdCapital, Inc. and Sidoti & Company LLC acted as co-managers for the offering in the United States. Canaccord Genuity Corp. acted as lead underwriter in connection with the offering in Canada.

Atlas filed a registration statement on Form S-1 (File No. 333-183276), including a prospectus, with the SEC for the offering, which was declared effective by the SEC on February 11, 2013. The offering was also made in Canada pursuant to a short form prospectus filed in the provinces of Ontario, Alberta and British Columbia. Prospective investors should read the prospectus in the registration statement and other documents that the Company has filed for more complete information about the Company and the offering. Investors may obtain these documents without charge by visiting EDGAR on the SEC or SEDAR websites at www.sec.gov and www.sedar.com, respectively. Alternatively, copies of the U.S. written prospectus may be obtained from Sandler O’Neill + Partners, 1251 Avenue of The Americas, 6th Floor, New York, NY 10020, (866) 805-4128, and copies of the Canadian short form prospectus may be obtained from Canaccord Genuity Corp., 161 Bay Street, 30th Floor, Toronto, Ontario, Canada, M5J 2S1.

The offering was made only by means of a written prospectus forming a part of the effective registration statement.

This news release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

About Atlas Financial Holdings, Inc.

The primary business of Atlas is commercial automobile insurance in the United States, with a niche market orientation and focus on insurance for the “light” commercial automobile sector including taxi cabs, non-emergency paratransit, limousine/livery and business auto. The business of Atlas is carried on through its …read more
Source: FULL ARTICLE at DailyFinance